Common Stock, Shares, Outstanding of Niagen Bioscience, Inc. from 01 Jan 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Niagen Bioscience, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 01 Jan 2011 to 31 Dec 2025.
  • Niagen Bioscience, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 79,714,000, a 3.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Niagen Bioscience, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 79,714,000 +2,384,000 +3.1% 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q3 2025 79,639,000 +3,612,000 +4.8% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 79,586,000 +4,113,000 +5.4% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 78,433,000 +3,280,000 +4.4% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 77,330,000 +2,349,000 +3.1% 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q3 2024 76,027,000 +1,117,000 +1.5% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 75,473,000 +617,000 +0.82% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 75,153,000 +487,000 +0.65% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 74,981,000 +414,000 +0.56% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 74,910,000 +6,741,000 +9.9% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 74,856,000 +6,701,000 +9.8% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 74,666,000 +6,517,000 +9.6% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 74,567,000 +6,441,000 +9.5% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 68,169,000 +75,000 +0.11% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 68,155,000 +146,000 +0.22% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 68,149,000 +447,000 +0.66% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 68,126,000 +6,245,000 +10% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 68,094,000 +6,507,000 +11% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 68,009,000 +6,588,000 +11% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 67,702,000 +8,097,000 +14% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 61,881,000 +2,319,000 +3.9% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q3 2020 61,587,000 +2,204,000 +3.7% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 61,421,000 +61,365,616 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 59,605,000 +59,549,679 31 Mar 2020 10-Q 18 May 2020 2020 Q1
Q4 2019 59,562,000 +59,506,911 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 59,383,000 +59,328,081 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 55,384* +514 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 55,321* +640 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 55,089* -54,641,911 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q3 2018 54,919* -47,595,333 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 54,870* -45,517,021 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 54,681* -37,863,367 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 54,697,000 +17,152,469 +46% 30 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 47,650,252 +10,107,054 +27% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 45,571,891 +8,081,977 +22% 01 Jul 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 37,918,048 +1,737,199 +4.8% 01 Apr 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 37,544,531 +1,540,942 +4.3% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 37,543,198 -68,776,408 -65% 01 Oct 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 37,489,914 -68,800,889 -65% 02 Jul 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 36,180,849 -69,806,209 -66% 02 Apr 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 36,003,589 -69,267,469 -66% 02 Jan 2016 10-K 16 Mar 2017 2016 FY
Q3 2015 106,319,606 +1,079,621 +1% 03 Oct 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 106,290,803 +1,574,961 +1.5% 04 Jul 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 105,987,058 +1,427,957 +1.4% 04 Apr 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 105,271,058 +746,320 +0.71% 03 Jan 2015 10-K 17 Mar 2016 2015 FY
Q3 2014 105,239,985 +4,420,321 +4.4% 27 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 104,715,842 +3,908,678 +3.9% 28 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 104,559,101 +8,551,218 +8.9% 29 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 104,524,738 +12,384,676 +13% 28 Dec 2013 10-K 19 Mar 2015 2014 FY
Q3 2013 100,819,664 +9,169,602 +10% 28 Sep 2013 10-Q 21 Nov 2013 2013 Q3
Q2 2013 100,807,164 +10,493,330 +12% 29 Jun 2013 10-Q/A 05 Dec 2013 2013 Q2
Q1 2013 96,007,883 +7,803,335 +8.8% 30 Mar 2013 10-Q/A 05 Dec 2013 2013 Q1
Q4 2012 92,140,062 +19,200,066 +26% 29 Dec 2012 10-K 27 Mar 2014 2013 FY
Q3 2012 91,650,062 +18,710,066 +26% 29 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 90,313,834 +24,595,268 +37% 30 Jun 2012 10-Q/A 10 Aug 2012 2012 Q2
Q1 2012 88,204,548 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 72,939,996 +12,064,671 +20% 31 Dec 2011 10-K 29 Mar 2013 2012 FY
Q3 2011 72,939,996 01 Oct 2011 10-Q 10 Nov 2011 2011 Q3
Q2 2011 65,718,566 02 Jul 2011 10-Q 11 Aug 2011 2011 Q2
Q4 2010 60,875,325 01 Jan 2011 10-K 15 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.